Single Puncture Arthrocentesis vs Double Puncture Arthrocentesis

April 27, 2020 updated by: Fatih TASKESEN, Erzincan University

Comparison of the Efficacy of Single and Double Puncture Arthrocentesis in Treatment of Temporomandibular Joint Disc Displacement Without Reduction

The aim of the present study was to compare the treatment efficacy of single puncture arthrocentesis (SPA) and double puncture arthrocentesis (DPA) techniques in Temporomandibular joint (TMJ) disc displacement without reduction (DDwoR).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Study sample consisted of 36 patients with DDwoR. 18 patients received SPA procedure and included in SPA group. The other 18 patients received DPA procedure and included in DPA group.

Double puncture arthrocentesis technique:

Posterior puncture method was used as described by Alkan and Etoz. for DPA. A straight line was drawn with a marker pen along the skin from the middle portion of the auricular tragus to the lateral chantus. The first puncture point was marked 10 mm anterior and 2 mm inferior to the tragus and the second 7 mm anterior and 2 mm inferior to the tragus. After local anesthesia, upper joint cavity was irrigated with 200 mL of Lactated Ringer's (RL) solution by inserting two 21- gauge needle. At the end of the procedure, after withdrawn of one of the needles, 1 mL of sodium hyaluronate (SH) was injected into the upper TMJ compartment through the other needle.

Single Puncture Arthrocentesis Technique:

SPA was performed with one needle (SPA Type-1 according to Senturk and Cambazoglu). The first reference point in DPA was used as the needle entry point fort he SPA. With this technique, the inflow and outflow of solution were provided through the same cannula and lumen of one 21-gauge needle as described by Guarda-Nardini et al. The joint was irrigated with 200 mL of RL solution under high pressure. At the end of the procedure1 mL of SH was injected through the needle.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Erzincan, Turkey
        • Erzincan Ağiz Ve Diş Sağlığı Egt Araş Hastanesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 59 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Temporomandibular joint (TMJ) disc displacement without reduction.
  • Restricted mouth opening

Exclusion criteria:

  • History of systemic disease effecting TMJ.
  • History of previous TMJ surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Single puncture arthrocentesis (SPA) group
Patients presenting temporomandibular joint disc displacement without reduction (DDwoR) treated with single puncture arthrocentesis
Temporomandibular joint arthrocentesis
ACTIVE_COMPARATOR: Double puncture arthrocentesis (DPA) group
Patients presenting temporomandibular joint disc displacement without reduction (DDwoR) treated with double puncture arthrocentesis
Temporomandibular joint arthrocentesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Rate of Pain on Function (PoF) assessed by Numerical Rating Scale (NRS)
Time Frame: baseline (t0)
Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)
baseline (t0)
The Rate of Pain on Function (PoF) assessed by Numerical Rating Scale (NRS)
Time Frame: At 1st week (t1)
Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)
At 1st week (t1)
The Rate of Pain on Function (PoF) assessed by Numerical Rating Scale (NRS)
Time Frame: at 1st month (t2)
Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 1st month (t2)
The Rate of Pain on Function (PoF) assessed by Numerical Rating Scale (NRS)
Time Frame: at 3rd month (t3)
Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 3rd month (t3)
The Rate of Pain on Function (PoF) assessed by Numerical Rating Scale (NRS)
Time Frame: at 6th month (t4)
Patients rated their pain on function (pain during chewing or speaking etc.) on a Numeric Rating Scale (NRS) (0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 6th month (t4)
The measurement of pain-free maximum mouth opening (MMO) in millimeters
Time Frame: baseline (t0)
Pain-free MMO was measured as the distance between the incisal edges of the upper and lower incisors while patient's mouth is open as possible without any assistance and without pain. Three measurements were performed, and their average is recorded.
baseline (t0)
The measurement of pain-free maximum mouth opening (MMO) in millimeters
Time Frame: at 1st week (t1)
Pain-free MMO was measured as the distance between the incisal edges of the upper and lower incisors while patient's mouth is open as possible without any assistance and without pain. Three measurements were performed, and their average is recorded.
at 1st week (t1)
The measurement of pain-free maximum mouth opening (MMO) in millimeters
Time Frame: at 1st month (t2)
Pain-free MMO was measured as the distance between the incisal edges of the upper and lower incisors while patient's mouth is open as possible without any assistance and without pain. Three measurements were performed, and their average is recorded.
at 1st month (t2)
The measurement of pain-free maximum mouth opening (MMO) in millimeters
Time Frame: at 3rd month (t3)
Pain-free MMO was measured as the distance between the incisal edges of the upper and lower incisors while patient's mouth is open as possible without any assistance and without pain. Three measurements were performed, and their average is recorded.
at 3rd month (t3)
The measurement of pain-free maximum mouth opening (MMO) in millimeters
Time Frame: at 6th month (t4)
Pain-free MMO was measured as the distance between the incisal edges of the upper and lower incisors while patient's mouth is open as possible without any assistance and without pain. Three measurements were performed, and their average is recorded.
at 6th month (t4)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of pain at rest (PaR) assessed by Numerical Rating Scale (NRS)
Time Frame: At Baseline (t0)
Patients rated their pain level at rest on a Numerical pain Scale (NRS) )(0-10 where 0 is no pain and 10 is the worst pain imaginable)
At Baseline (t0)
The rate of pain at rest (PaR) assessed by Numerical Rating Scale (NRS)
Time Frame: at 1st week (t1)
Patients rated their pain level at rest on a Numerical pain Scale (NRS) )(0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 1st week (t1)
The rate of pain at rest (PaR) assessed by Numerical Rating Scale (NRS)
Time Frame: at 1st month (t2)
Patients rated their pain level at rest on a Numerical pain Scale (NRS) )(0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 1st month (t2)
The rate of pain at rest (PaR) assessed by Numerical Rating Scale (NRS)
Time Frame: at 3rd month (t3)
Patients rated their pain level at rest on a Numerical pain Scale (NRS) )(0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 3rd month (t3)
The rate of pain at rest (PaR) assessed by Numerical Rating Scale (NRS)
Time Frame: at 6th month (t4)
Patients rated their pain level at rest on a Numerical pain Scale (NRS) )(0-10 where 0 is no pain and 10 is the worst pain imaginable)
at 6th month (t4)
Measurement of Duration of the Procedure in Minutes
Time Frame: at 1st day (At the end of the procedure)
Total time for arthrocentesis was noted at the end of the procedure
at 1st day (At the end of the procedure)
Measurement of the easiness of the procedure to the operator by using Visual Analog Scale (VAS)
Time Frame: at 1st day (At the end of the procedure)
The operator rated the degree of easiness of the procedure on a VAS as 0-very easy 10-very difficult to perform.
at 1st day (At the end of the procedure)
The rate of treatment tolerability assessed by 5-point Likert-type scale
Time Frame: 1st day
The degree to which overt adverse effects and post operative complications (pain, feeling of pressure in TMJ area and disturbing sound) can be tolerated by the patient. Patients were asked to rate the tolerability on a 5 point scale as 0- lowest, 4-highest.
1st day
The rate of treatment tolerability assessed by 5-point Likert-type scale
Time Frame: 1st week
The degree to which overt adverse effects and post operative complications (pain, feeling of pressure in TMJ area and disturbing sound) can be tolerated by the patient. Patients were asked to rate the tolerability on a 5 point scale as 0- lowest, 4-highest.
1st week
The rate of treatment tolerability assessed by 5-point Likert-type scale
Time Frame: 6th month
The degree to which overt adverse effects and post operative complications (pain, feeling of pressure in TMJ area and disturbing sound) can be tolerated by the patient. Patients were asked to rate the tolerability on a 5 point scale as 0- lowest, 4-highest.
6th month
The rate of chewing efficiency by using Visual Analog Scale (VAS)
Time Frame: at baseline (t0)
Patients rated the chewing efficiency on a VAS as 0-can only eat semi-liquid foods, 10-eat any solid-food.
at baseline (t0)
The rate of chewing efficiency by using Visual Analog Scale (VAS)
Time Frame: at 1st week (t1)
Patients rated the chewing efficiency on a VAS as 0-can only eat semi-liquid foods, 10-eat any solid-food.
at 1st week (t1)
The rate of chewing efficiency by using Visual Analog Scale (VAS)
Time Frame: at 1st month (t2)
Patients rated the chewing efficiency on a VAS as 0-can only eat semi-liquid foods, 10-eat any solid-food.
at 1st month (t2)
The rate of chewing efficiency by using Visual Analog Scale (VAS)
Time Frame: at 3rd month (t3)
Patients rated the chewing efficiency on a VAS as 0-can only eat semi-liquid foods, 10-eat any solid-food.
at 3rd month (t3)
The rate of chewing efficiency by using Visual Analog Scale (VAS)
Time Frame: at 6th month (t4)
Patients rated the chewing efficiency on a VAS as 0-can only eat semi-liquid foods, 10-eat any solid-food.
at 6th month (t4)
Rate of perceived effectiveness of the treatment by using 5-point Likert-type scale
Time Frame: at 6th month
Patients rated the subjective treatment effectiveness on a 5-point scale as 0- lowest, 4 highest values.
at 6th month
Measurement of Lateral Movement of the mandible towards the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at baseline (t0)
Lateral Movement of the mandible towards the affected Temporomandibular joint (LT) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted towards the affected TMJ. Three measurements were performed, and their average is recorded.
at baseline (t0)
Measurement of Lateral Movement of the mandible towards the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 1st week (t1)
Lateral Movement of the mandible towards the affected Temporomandibular joint (LT) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted towards the affected TMJ. Three measurements were performed, and their average is recorded.
at 1st week (t1)
Measurement of Lateral Movement of the mandible towards the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 1st month (t2)
Lateral Movement of the mandible towards the affected Temporomandibular joint (LT) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted towards the affected TMJ. Three measurements were performed, and their average is recorded.
at 1st month (t2)
Measurement of Lateral Movement of the mandible towards the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 3rd month (t3)
Lateral Movement of the mandible towards the affected Temporomandibular joint (LT) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted towards the affected TMJ. Three measurements were performed, and their average is recorded.
at 3rd month (t3)
Measurement of Lateral Movement of the mandible towards the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 6th month (t4)
Lateral Movement of the mandible towards the affected Temporomandibular joint (LT) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted towards the affected TMJ. Three measurements were performed, and their average is recorded.
at 6th month (t4)
Measurement of Lateral Movement of the mandible away from the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at baseline (t0)
Lateral Movement of the mandible away from the affected Temporomandibular joint (LA) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted away from the affected TMJ. Three measurements were performed, and their average is recorded.
at baseline (t0)
Measurement of Lateral Movement of the mandible away from the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 1st week (t1)
Lateral Movement of the mandible away from the affected Temporomandibular joint (LA) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted away from the affected TMJ. Three measurements were performed, and their average is recorded.
at 1st week (t1)
Measurement of Lateral Movement of the mandible away from the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 1st month (t2)
Lateral Movement of the mandible away from the affected Temporomandibular joint (LA) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted away from the affected TMJ. Three measurements were performed, and their average is recorded.
at 1st month (t2)
Measurement of Lateral Movement of the mandible away from the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 3rd month (t3)
Lateral Movement of the mandible away from the affected Temporomandibular joint (LA) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted away from the affected TMJ. Three measurements were performed, and their average is recorded.
at 3rd month (t3)
Measurement of Lateral Movement of the mandible away from the affected Temporomandibular joint (TMJ) in millimeters
Time Frame: at 6th month (t4)
Lateral Movement of the mandible away from the affected Temporomandibular joint (LA) was measured as the distance between the midlines of the upper and lower incisors by a caliper while patient's mandible was shifted away from the affected TMJ. Three measurements were performed, and their average is recorded.
at 6th month (t4)
Measurement of protrusive movement of the mandible in millimeters
Time Frame: at baseline (t0)
Protrusive movement of the mandible was measured as the distance in horizontal direction between the incisal edges of upper and lower incisors by a caliper when mandible moves forward.
at baseline (t0)
Measurement of protrusive movement of the mandible in millimeters
Time Frame: at 1st week (t1)
Protrusive movement of the mandible was measured as the distance in horizontal direction between the incisal edges of upper and lower incisors by a caliper when mandible moves forward.
at 1st week (t1)
Measurement of protrusive movement of the mandible in millimeters
Time Frame: at 1st month (t2)
Protrusive movement of the mandible was measured as the distance in horizontal direction between the incisal edges of upper and lower incisors by a caliper when mandible moves forward.
at 1st month (t2)
Measurement of protrusive movement of the mandible in millimeters
Time Frame: at 3rd month (t3)
Protrusive movement of the mandible was measured as the distance in horizontal direction between the incisal edges of upper and lower incisors by a caliper when mandible moves forward.
at 3rd month (t3)
Measurement of protrusive movement of the mandible in millimeters
Time Frame: at 6th month (t4)
Protrusive movement of the mandible was measured as the distance in horizontal direction between the incisal edges of upper and lower incisors by a caliper when mandible moves forward.
at 6th month (t4)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Fatih TASKESEN, Erzincan Binali Yildirim University Faculty of Dentistry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2017

Primary Completion (ACTUAL)

November 1, 2019

Study Completion (ACTUAL)

December 1, 2019

Study Registration Dates

First Submitted

April 3, 2020

First Submitted That Met QC Criteria

April 27, 2020

First Posted (ACTUAL)

April 29, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 29, 2020

Last Update Submitted That Met QC Criteria

April 27, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 135163

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthrocentesis

Clinical Trials on TMJ Arthrocentesis

Subscribe